About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials | 951 Studies Recruiting

Clinical TrialsBrain Cancer

Brain Cancer Clinical Trials

Browse 951 clinical trials for brain cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 951 trials

CompletedSorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade GliomaThe purpose of this research study is to test the safety, tolerability, and effectiveness of the combination of three drugs, sorafenib (Nexavar®), valproic acid (Depakote®), and…NCT01817751·Richmond, Virginia RecruitingA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent GlioblastomaThis multi-site Phase II study will enroll adults with histologically confirmed diagnosis of World Health Organization (WHO) Grade IV glioblastoma (GBM), isocitrate dehydrogenase…NCT07297212·Beijing and 5 others RecruitingFearLess in NeuroOncologyThe overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize…NCT06989086·Richmond, Virginia CompletedPh. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideObjective: To determine activity of combo of Irinotecan + Temozolomide To further characterize any toxicity associated w combo of Irinotecan + TemozolomideNCT00616005·Durham, North Carolina

Related Searches

glioblastomatrials gliomatrials brain tumortrials

Data from ClinicalTrials.govTerms

RecruitingSonodynamic Therapy in Patients With Recurrent GBMPatients diagnosed with glioblastoma (GBM) are faced with limited treatment options.NCT06039709·Charlottesville, Virginia

CompletedMotexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003409·Los Angeles, California and 1 other

CompletedRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain TumorsRATIONALE: Monoclonal antibodies can locate tumor cells and deliver radioactive tumor-killing substances such as radioactive iodine to them without harming normal cells.NCT00003478·Durham, North Carolina

CompletedIrinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain TumorRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004068·Memphis, Tennessee

CompletedImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaRATIONALE: Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01273090·Birmingham, Alabama and 22 others

WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsThis pilot clinical trial studies gallium Ga 68-edotreotide (68Ga-DOTATOC) positron emission tomography (PET)/computed tomography (CT) in finding brain tumors in younger patients.NCT02194452·Iowa City, Iowa

CompletedBevacizumab in Treating Patients With Recurrent or Progressive GliomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00337207·Chicago, Illinois and 1 other

RecruitingExtensive Resection of Malignant Brain Tumors Using Advanced Imaging TechniquesRationale: Patients with IDH-wildtype glioblastoma or grade IV IDH-mutant astrocytoma have a very poor prognosis despite standard treatment consisting of surgery, radiotherapy…NCT06623565·Amsterdam, North Holland

CompletedEfficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsThis is a prospective, single-arm, two stages, open-label, pilot study to investigate the efficacy and safety of FUS add-on bevacizumab (BEV) in rGBM patients.NCT04446416·Taoyuan City

RecruitingFeasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System LesionsThis clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intra- and post-operative microdialysis…NCT04047264·Rochester, Minnesota

CompletedKarenitecin in Treating Patients With Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00014521·Birmingham, Alabama and 7 others

RecruitingA Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsThis will be a prospective, randomized, standard of care (SoC) controlled, parallel, open-label, multicenter pivotal study to investigate the efficacy and safety of Bevacizumab…NCT06496971·Taipei and 1 other

Active not recruitingBrain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaThis phase I trial investigates the side effects of brain tumor-specific immune cells (IL13Ralpha2-CAR T cells) in treating patients with leptomeningeal disease from glioblastoma…NCT04661384·Duarte, California

CompletedImmunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaRATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. Immunotoxin therapy may be effective in treating malignant glioma.NCT00036972·New York, New York

CompletedStudy of Tissue Samples From Patients With Glioma or Other Brain TumorsRATIONALE: Studying the genes expressed in samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify…NCT00967200·Montpellier and 1 other

CompletedNBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma MultiformeRATIONALE: NBI-3001 may be able to locate cancer cells and stop them from growing. This may be an effective treatment for glioblastoma multiforme.NCT00014677·La Jolla, California and 3 others

PreviousPage 14 of 48Next